论文部分内容阅读
目的观察头孢曲松联合头孢克肟胶囊治疗呼吸道感染的疗效。方法选取2013年2月至2015年2月诊断为的患者,疾病类型为支气管炎、肺炎等。随机分为50例研究组(接受头孢曲松+头孢克肟治疗)和50例对照组(接受头孢曲松治疗)。对比(1)研究组和对照组住院费用。(2)研究组和对照组呼吸道感染疗效。结果(1)研究组和对照组住院费用比较差异有统计学意义(P<0.05)。(2)研究组和对照组呼吸道感染治疗有效率分别为98%、96%,结果比较差异无统计学意义(P>0.05)。结论头孢曲松和头孢克肟序贯治疗呼吸道感染不仅疗效肯定,而且费用少。
Objective To observe the efficacy of ceftriaxone combined with cefixime capsules in the treatment of respiratory tract infections. Methods Patients who were diagnosed from February 2013 to February 2015 were selected and their disease types were bronchitis and pneumonia. Randomly divided into 50 cases of study group (receiving ceftriaxone + cefixime treatment) and 50 cases of control group (receiving ceftriaxone treatment). Comparison (1) Study group and control group hospitalization costs. (2) The efficacy of respiratory tract infection in study group and control group. Results (1) There was significant difference in hospitalization costs between study group and control group (P <0.05). (2) The response rates of respiratory tract infection in study group and control group were 98% and 96% respectively, with no significant difference (P> 0.05). Conclusion Ceftriaxone and cefixime sequential treatment of respiratory tract infection is not only effective, but less costly.